Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 2
1987 1
1988 1
1989 1
1990 1
1991 1
1993 5
1994 7
1995 2
1996 6
1997 7
1998 8
1999 8
2000 7
2001 9
2002 6
2003 3
2004 9
2005 13
2006 15
2007 10
2008 8
2009 5
2010 12
2011 12
2012 12
2013 7
2014 5
2015 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Results by year
Filters applied: . Clear all
Page 1
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Rieder MJ, et al. N Engl J Med. 2005 Jun 2;352(22):2285-93. doi: 10.1056/NEJMoa044503. N Engl J Med. 2005. PMID: 15930419 Free article.
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E. Kuehl P, et al. Nat Genet. 2001 Apr;27(4):383-91. doi: 10.1038/86882. Nat Genet. 2001. PMID: 11279519
Mass spectrometry.
Burlingame AL, Baillie TA, Derrick PJ. Burlingame AL, et al. Anal Chem. 1986 Apr;58(5):165R-211R. doi: 10.1021/ac00296a015. Anal Chem. 1986. PMID: 3521386 Review. No abstract available.
Rearrangement reactions catalyzed by cytochrome P450s.
Ortiz de Montellano PR, Nelson SD. Ortiz de Montellano PR, et al. Arch Biochem Biophys. 2011 Mar 1;507(1):95-110. doi: 10.1016/j.abb.2010.10.016. Epub 2010 Oct 29. Arch Biochem Biophys. 2011. PMID: 20971058 Free PMC article. Review.
Interactions of cytochrome P450s with their ligands.
Conner KP, Woods CM, Atkins WM. Conner KP, et al. Arch Biochem Biophys. 2011 Mar 1;507(1):56-65. doi: 10.1016/j.abb.2010.10.006. Epub 2010 Oct 19. Arch Biochem Biophys. 2011. PMID: 20939998 Free PMC article. Review.
Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib.
Ho HK, Chan JC, Hardy KD, Chan EC. Ho HK, et al. Drug Metab Rev. 2015 Feb;47(1):21-8. doi: 10.3109/03602532.2014.1003648. Epub 2015 Feb 2. Drug Metab Rev. 2015. PMID: 25639891 Free PMC article. Review.
In vitro-to-in vivo predictions of drug-drug interactions involving multiple reversible inhibitors.
Lutz JD, Isoherranen N. Lutz JD, et al. Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):449-66. doi: 10.1517/17425255.2012.667801. Epub 2012 Mar 3. Expert Opin Drug Metab Toxicol. 2012. PMID: 22384784 Review.
The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.
VandenBrink BM, Isoherranen N. VandenBrink BM, et al. Curr Opin Drug Discov Devel. 2010 Jan;13(1):66-77. Curr Opin Drug Discov Devel. 2010. PMID: 20047147 Free PMC article. Review.
Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance.
Totah RA, Rettie AE. Totah RA, et al. Clin Pharmacol Ther. 2005 May;77(5):341-52. doi: 10.1016/j.clpt.2004.12.267. Clin Pharmacol Ther. 2005. PMID: 15900280 Review.
Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics.
Rettie AE, Jones JP. Rettie AE, et al. Annu Rev Pharmacol Toxicol. 2005;45:477-94. doi: 10.1146/annurev.pharmtox.45.120403.095821. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822186 Review.
176 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback